Vivienne Walt

Paris

Correspondent, Paris at Fortune

Correspondent, Europe at TIME

TIME Correspondent. Fortune Correspondent. @PulitzerCenter grantee. @opcofamerica board member. Home Paris, travels anywhere. DM ideas. Always curious.

Featured in: Favicon

fortune.com Favicon

time.com

cnn.com

forbes.com Favicon

msn.com

nytimes.com Favicon

bloomberg.com Favicon

yahoo.com (+6) Favicon

latimes.com Favicon

npr.org + 93 more

Articles

Duma Boko

4 weeks ago | yahoo.com | Vivienne Walt

Credit - Jonas Roosens—Belga/ReutersFew predicted the seismic election upset that made Duma Boko President of Botswana. Last October, the 55-year-old Harvard-trained lawyer ousted the party that had ruled the nation of 2.5 million people since its independence from Britain nearly 60 years ago. But in hindsight, the outcome seems almost inevitable.
Corporate Gloom Rises Over Trump's Tariffs

1 month ago | nytimes.com | Andrew Ross Sorkin |Ravi Mattu |Bernhard Warner |Sarah Kessler |Lauren Hirsch |Edmund Lee | +1 more

Investors are breathing a bit easier on Monday, with markets rallying in Asia and Europe on hopes for a reprieve on tech tariffs. The optimism seems to contradict President Trump's own words. The president has signaled that yet another round of levies are on the way, sowing more confusion among business leaders about what's on, what's off - and how to deal with their new reality. Is Trump undermining his own position?
What Is Trump's Tariff Endgame? Recession Fears Grow.

1 month ago | nytimes.com | Andrew Ross Sorkin |Ravi Mattu |Bernhard Warner |Sarah Kessler |Lauren Hirsch |Edmund Lee | +1 more

Broad new tariffs on U.S. trading partners went into effect a few hours ago, including huge penalties for those on President Trump's "worst offenders" list. Up next: the threat of additional levies on pharmaceutical imports. The moves have hit jittery investors in the gut yet again, with bonds, Asian and European stocks and oil sharply lower on fears for the global economy.
Ozempic and Wegovy pumped $26 billion into Novo Nordisk last year. Can the pharma giant find its next breakthrough before the boom ends?

1 month ago | fortune.com | Vivienne Walt

Cranes loom over Novo Nordisk’s fast-growing factory hub in Kalundborg, Denmark. Patrick Brown/Panos Pictures for Fortune
At the Paris AI summit, the tech world asks: Does Europe's tech culture drive startups away?

Feb 13, 2025 | fortune.com | Vivienne Walt

French President Emmanuel Macron (R) speaks with Sam Altman, CEO of OpenAI, during the AI Action Summit in Paris, on Feb. 11, 2025. Europe's also-ran status in the AI race was painfully apparent at the global conference. AURELIEN MORISSARD/POOL/AFP—Getty Images
Markets Play Down the Hit From Trump's Latest Trade Fight

Feb 10, 2025 | nytimes.com | Andrew Ross Sorkin |Ravi Mattu |Bernhard Warner |Sarah Kessler |Lauren Hirsch |Edmund Lee | +1 more

Image President Trump has ramped up the tariff war. This time, the markets reaction has been muted. Credit... Pete Marovich for The New York Times Hope you enjoyed the Super Bowl on Sunday night, and congrats to the Philadelphia Eagles. The ads were better than the game. We've got a rundown below. I got into a substantive debate on Sunday with Joe Lonsdale, the venture capitalist and co-founder of Palantir, and other investors, about how carried interest is taxed.
Meta and Microsoft Double Down on Huge A.I. Spending, Despite DeepSeek Threat

Jan 30, 2025 | nytimes.com | Andrew Ross Sorkin |Ravi Mattu |Bernhard Warner |Sarah Kessler |Lauren Hirsch |Edmund Lee | +1 more
Taking Trump's Tariffs Threats Seriously and Literally

Jan 22, 2025 | nytimes.com | Andrew Ross Sorkin |Ravi Mattu |Bernhard Warner |Sarah Kessler |Lauren Hirsch |Vivienne Walt | +2 more

Image President Trump may see tariffs as a revenue source and not just as a negotiating tactic, some analysts now say. Credit... Doug Mills/The New York Times President Trump's tariff threats have perplexed and rankled foreign leaders and C.E.O.s for some time now as they fear the unleashing of a tit-for-tat trade war. Investors apparently feel relieved that he has held off so far, with S&P 500 futures gaining this morning.
글로벌 최대 맥주회사 CEO의 고민 “술 안 먹는 청년들”

Nov 21, 2024 | fortunekorea.co.kr | Vivienne Walt

최근 하버드 경영대학원에서 여러 최고경영자를 초청해 전용 세미나를 열었다. 세미나는 참석자들에게 자신의 평균 재임 기간 동안 직면할 가능성이 높은 4가지 위기를 상상해보라고 요청했다. 그 위기는 보건 비상사태, 지정학적 갈등, 경제 침체, 무역 전쟁이었다. 특히 한 참가자에게 이 목록은 깊은 인상을 남겼다. 세계 최대 주류 회사인 안호이저-부시 인베브의 CEO 미셸 두케리스의 메모다. "당신들의 연구에 따르면 나는 은퇴할 준비가 된 것 같다. 임기 첫 2년 동안 그 모든 것을 겪었으니까." 두케리스는 2021년 7월 AB 인베브를 이끌게 됐다. 그의 취임은 코로나19 대유행이 절정에 달했을 때였다. 당시 수백만 명의 음주자들이 봉쇄 조치 하에 있거나 붐비는 술집에서의 음주를 피하고 있었다. 이어서 러시아의 우크라이나 침공, 글로벌 인플레이션 급증, 세계 최대 경제 대국인 미국과 중국 간의 무역 분쟁 심화가 뒤따랐다.
Gen Z are drinking less than their parents. The CEO in charge of Bud Light and Michelob is betting on nonalcoholic beer to woo them back

Nov 21, 2024 | finance.yahoo.com | Vivienne Walt

During a recent invite-only seminar at Harvard Business School, a group of CEOs were asked to imagine the four crises they would likely confront during their average tenure at the top: a health emergency, a geopolitical conflict, an economic downturn, and a trade war. For one participant in particular—Michel Doukeris, CEO of the world’s biggest brewer, Anheuser-Busch InBev—the list hit home. “So, according to your research, I’m ready to retire,” he recalls telling the Harvard professor.